Evidence map›Paper›PMID 30873495›Full record

ArticleJournal of clinical and translational research2018

Inclusion of special populations in clinical research: important considerations and guidelines.

Stuart S Winter, Janet M Page-Reeves, Kimberly A Page, Emily Haozous, Angelica Solares, Carla Nicole Cordova, Richard S Larson

Open access · diamondAbstract read
In one paragraph

Article in Journal of clinical and translational research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Results and Strategies for a Diversity-Oriented Public Health Monitoring in Germany.International journal of environmental research and public health · 2022
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Managing Atopic Dermatitis with Dupilumab in Special Populations: A Case Series Study.Clinical, cosmetic and investigational dermatology · 2025
    Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Stuart S WinterChildren's Minnesota Research Institute, Minneapolis, MN, United States.
Janet M Page-ReevesDepartment of Family and Community Medicine, University of New Mexico, Albuquerque, United States.
Kimberly A PageDepartment of Internal Medicine, Division of Epidemiology, Biostatistics and Preventive Medicine, University of New Mexico, Albuquerque, United States.
Emily HaozousUNM College of Nursing, University of New Mexico, Albuquerque, United States.
Angelica SolaresUniversity of New Mexico School of Law, University of New Mexico, Albuquerque, United States.
Carla Nicole CordovaUNM Clinical and Translational Science Center, University of New Mexico, Albuquerque, United States.
Richard S LarsonUNM Clinical and Translational Science Center, University of New Mexico, Albuquerque, United States.
University of New Mexico · USChildren's Minnesota · US

Funding

Transdisciplinary Research, Equity and Engagement Center for Advancing Behavioral HealthU54MD004811 · NIMHD · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CACARI STONE, LISA MARIE, CRUZ, THERESA · 2017 to 2022
$8.7M
ELIMINATING HEALTH INEQUITIES THROUGH RESEARCH EDUCATION AND MENTORSHIPP20MD004996 · NIMHD · UNIVERSITY OF NEW MEXICO · PI CACARI STONE, LISA MARIE, VALDEZ, ROBERT OTTO · 2009 to 2010
$2.2M
NIMHD NIH HHS P20 MD004996NIMHD NIH HHS U54 MD004811
6 · The paper itself

Abstract

backgroundTrials that involve human participants call for experiments or observations that are performed in a clinical research setting. Currently, there are over 16,000 clinical trials open in the United States. Despite continuing efforts to include "special populations" in clinical trials, there are gaps in participation for people who are either minors or elderly adults, are from historically under-represented minorities, or live in rural communities. The inclusion of these special populations in clinical trials research is essential for conclusions that benefit all populations. Data suggest that study partic-ipation rates for special populations have fallen to levels that could endanger the successful performance of some types of research. This is particularly concerning in the 21st century, where demographic trends in the United States continue to shift towards an older and Hispanic population with fewer rural dwellers. Trends in New Mexico and other minority-majority states mirror many of these shifts. RELEVANCE FOR PATIENTS: In this review, we highlight improvement strategies for enhanced clinical trial participation by members of special populations. Key drivers for disparate clinical trials participation and outcomes often include differences in genetics, physiology, and perceptions of mistrust towards researchers. To overcome these barriers, we focus on best practices in recruitment strategies from the perspectives of the participants, the researchers and the institutions that support clinical trials.

Indexed as

accrualbest practicesclinical trialspopulationsretentionspecial

Identifiers

PMID30873495
PMCPMC6410628
OpenAlexW2995167968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.